Yes, I'm with you funny blue bird, I'm fairly out of pocket on it, but the potential v market cap seems compelling. I also like the way they are slowly lining up their ducks to make sure the one shot in the locker has the best chance. I wish a few more of my biotech holdings had done that before blowing millions on failed trials.
